Efficacy And Safety Of Ipragliflozin, An Sglt2 Inhibitor, Add-On To Insulin In Japanese Patients: Results Of A Double-Blind, Placebo-Controlled Study
DIABETES（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined